Wieser Karl, Farshad Mazda, Meyer Dominik C, Conze Philipp, von Rechenberg Brigitte, Gerber Christian
Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Forchstrasse 340, 8008, Zurich, Switzerland,
Knee Surg Sports Traumatol Arthrosc. 2015 Feb;23(2):577-84. doi: 10.1007/s00167-014-3037-y. Epub 2014 May 4.
Chronic tearing of tendons is associated with molecular and structural alterations causing biomechanical changes, which compromise musculotendinous function and become limiting factors for tendon repair. This study investigated the histological response of chronically retracted sheep rotator cuff tendons to mechanical and pharmacological stimulation in view of tendon repair.
Sixteen weeks after experimental release of the infraspinatus tendon in 20 sheep, the retracted musculotendinous unit was subjected to continuous traction either with [anabolic steroids (nandrolone) group/insulin-like growth factor (IGF) group] or without (control group) additional pharmacological treatment during 6 weeks. A new degeneration score for tendinous tissues (DSTT), based on established knowledge on histological changes associated with tendon degeneration, was used for histological analysis at the time of tendon release, at the beginning of continuous re-lengthening and at repair in all animals.
The DSTT score (inter-observer correlation: r = 0.83), quantifiably representing tendon degeneration, improved from 15.5 (SD 1.3) points before to 9.8 (SD 3.8) points after re-lengthening. It improved in a qualitatively and quantitatively similar fashion if pharmacological stimulation was added. The nandrolone group improved from 13.7 (SD 1.6) to 9.8 (SD 1.9) and the IGF group from 13.3 (SD 3.6) to 8.8 (SD 1.8) points.
Mechanical stimulation significantly reduced tissue degeneration. However, the addition of a pharmacological stimulation with anabolic steroids or IGF had neither a measurable positive nor negative effect on the degenerative process. Therefore, this investigation does neither support the additional pharmacological use of the anabolic steroid nandrolone or of IGF decanoate for restoration of tendon degeneration, nor otherwise provide evidence for additional tendon damage, if those substances are used to alter the muscular metabolism.
肌腱的慢性撕裂与分子和结构改变相关,这些改变会引起生物力学变化,进而损害肌肉肌腱功能,并成为肌腱修复的限制因素。本研究鉴于肌腱修复,调查了慢性回缩的绵羊肩袖肌腱对机械和药物刺激的组织学反应。
在20只绵羊的冈下肌腱进行实验性松解16周后,对回缩的肌肉肌腱单元在6周内进行持续牵引,一组接受额外的药物治疗(合成代谢类固醇(诺龙)组/胰岛素样生长因子(IGF)组),另一组不接受(对照组)。基于与肌腱退变相关的组织学变化的现有知识,采用一种新的肌腱组织退变评分(DSTT),对所有动物在肌腱松解时、持续再延长开始时和修复时进行组织学分析。
DSTT评分(观察者间相关性:r = 0.83)可量化地表示肌腱退变,从再延长前的15.5(标准差1.3)分改善至9.8(标准差3.8)分。如果添加药物刺激,其改善的质量和数量方式相似。诺龙组从13.7(标准差1.6)分改善至9.8(标准差1.9)分,IGF组从13.3(标准差3.6)分改善至8.8(标准差1.8)分。
机械刺激显著降低了组织退变。然而,添加合成代谢类固醇或IGF的药物刺激对退变过程既没有可测量的积极影响也没有消极影响。因此,本研究既不支持额外使用合成代谢类固醇诺龙或癸酸IGF来恢复肌腱退变,也没有提供证据表明如果使用这些物质改变肌肉代谢会造成额外的肌腱损伤。